Project Grant HT94252311003
Award Date
9/30/23
Completion Date
9/29/27
Dollars Obligated
$7.7M
Federal Agency
Defense Health Agency
Federal Grant Program
12.420
Assistance Type
Project Grant
Place of Performance
Columbus, OH 43210, USA
Similar Awards
The Ohio State University received a $248,237 Project Grant award from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420). The award will fund a 3-year project from July 1, 2023 to June 30, 2026 to research and address traumatic brain injuries among law enforcement officers. No additional details about specific products or services to be delivered under this award were provided. The Military Medical Research and Development program supports basic,...
This $249,960 Project Grant award from the Defense Health Agency's Military Medical Research and Development program (CFDA 12.420) supports research conducted by The Ohio State University to investigate the effects of the aged inflammatory central nervous system (CNS) microenvironment on oligodendroglial properties and remyelination capacity. The research aims to advance scientific understanding of age-related changes in the CNS that can impact myelin repair, with potential applications for...
The Defense Health Agency awarded a $512,751.00 Project Grant to The Ohio State University for the period from July 1, 2023 to June 30, 2026. The grant was provided under the Military Medical Research and Development program (CFDA 12.420), which supports basic, applied, and advanced biomedical research to transform healthcare for Service Members and the American public through innovative and impactful research, and to investigate medical solutions for the battlefield. The grant funds will...
This federal Project Grant award of $267,311 was provided by the Defense Health Agency under the Military Medical Research and Development (CFDA 12.420) program. The grant supports a randomized clinical trial utilizing crisis response planning for suicide prevention in military personnel with traumatic brain injury. The award was made to The Ohio State University, which will serve as the prime recipient, with a performance period from August 1, 2024 to July 31, 2027. The project aims to...
This Project Grant award of $717,896.00 was provided by the Defense Health Agency to The Ohio State University under the Military Medical Research and Development program (CFDA 12.420). The purpose of the award is to conduct research on prebiotic and probiotic interventions for the treatment of traumatic brain injury (TBI)-induced microbiome dysfunction. The Ohio State University is the prime awardee, and they have issued a $XXX,XXX subaward to the Research Institute at Nationwide Children's...
The federal Project Grant award "PRESERVING VISION AFTER NEUROTRAUMA (PREVANT)" was provided by the Defense Health Agency under CFDA Program 12.420 - Military Medical Research and Development. The $1,479,970.00 award to The Ohio State University, with a performance period from July 15, 2025 to July 14, 2029, will support advanced biomedical research aimed at transforming healthcare for military service members, veterans, and the broader public. The research will focus on innovative...
The federal Project Grant award "PRESERVING VISION AFTER NEUROTRAUMA (PREVANT)" was provided by the Defense Health Agency under the Military Medical Research and Development (CFDA 12.420) program. The $1,465,907 award, made on Jul 15, 2025, supports advanced biomedical research at The Ohio State University (OSU) aimed at transforming healthcare for military service members, veterans, and the broader public. The project will focus on innovative research to address critical health...
This Project Grant award from the Department of the Army Medical Command under the Military Medical Research and Development program (CFDA 12.420) provides $1,181,250.00 to The Ohio State University to conduct research on the use of MIF inhibition and glucocorticoid therapeutics as a synergistic treatment to promote neuronal survival in traumatic retinal injury. The research aims to develop novel therapies for this type of injury, which is of particular relevance to military personnel. The...
This $1,000,000.00 federal Project Grant award was provided by the Defense Health Agency under the Military Medical Research and Development (CFDA 12.420) program. The grant supports advanced biomedical research focused on investigating whether the gut microbiome coordinates with the gut-brain axis to contribute to behavioral alterations and cognitive injuries following traumatic brain injury (TBI), and if these effects are more profound in individuals with the APOE E4 genetic variant. The prime...
The Department of the Army Medical Command awarded a $2,289,304.00 Project Grant under the Military Medical Research and Development (CFDA 12.420) federal grant program to The Medical College of Wisconsin, Inc. The grant, with a performance period from August 1, 2024 to July 31, 2027, is funding research to improve in-hospital and post-discharge patient education for mild traumatic brain injury. The grant includes a sub-award to The Ohio State University to support this research initiative....